BioSpace News Archive

Frontier Medicines Corporation today announced the appointment of Pasi A. Jänne, M.D., Ph.D., director of the Lowe Center for Thoracic Oncology and director of the Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute, to its Scientific Advisory Board (SAB).

AIM ImmunoTech Inc. today announced that it will participate in the Virtual Investor Innovations in Oncology Spotlight Series on Monday, July 25, 2022 at 8:30 AM ET.

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the initiation of an expanded access program (EAP) for voxelotor in Brazil for the treatment of sickle cell disease (SCD) in adult and pediatric patients 12 years of age and older who cannot satisfactorily be treated with a medicine authorized for use in Brazil.

Genetic Technologies Limited is delighted to announce that it has completed the acquisition of the direct-to-consumer eCommerce business and distribution rights associated with AffinityDNA as announced on May 16, 20221.

MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Cybersecurity is pleased to announce its key role in obtaining FDA marketing authorization for the Quell wearable neuromodulation device as an aid for reducing the symptoms of fibromyalgia in adults with high pain sensitivity.

Medlogix, a leading national medical claims management solutions provider, has announced that Mary Hartquist has joined the organization as a Sales Manager in the Northeast Region.

Recognized in the Wearable Category for the first-of-its-kind smart sensor platform for respiratory health, RESP ®.

Northwest Pathology, PLLC (NWP), today announced that with the December 2021 acquisition of Avero Diagnostics (Avero), NWP has adopted the Avero Diagnostics name for the combined business and service lines of Northwest Pathology, Northwest Laboratory (NWL), and Avero Diagnostics.

Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today an abstract has been accepted for an oral presentation at the ASRM 2022 Scientific Congress & Expo.

Manifold Bio , a next-generation protein therapeutics company pioneering an in vivo biologics design platform, today announced the close of a $40 million Series A financing round led by Triatomic Capital and joined by new investors Section 32, FPV Ventures, Horizons Ventures, and Tencent.